InvestorsHub Logo
Followers 35
Posts 4038
Boards Moderated 0
Alias Born 01/23/2018

Re: Diogenes of Sinope post# 1698

Wednesday, 03/18/2020 11:27:31 AM

Wednesday, March 18, 2020 11:27:31 AM

Post# of 3369
Q4 2019 net loss was $9.8 million, compared to net income of $1.9 million in the previous quarter. This loss was primarily due to non-cash items including a decline of $8.0 million in unrealized gain on fair value of biological assets compared to Q3 2019, and a non-cash $3.6 million deferred income tax expense in the quarter. Can someone explain this part to me? Thanks